Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001193125-26-004573

Chief Executive Officer sold 700 shares at $21.38 ($14,966)

  • Chief Executive Officer acquired 1,360 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schambye Hans T. Chief Executive Officer 2026-01-02 Option exercise +1,360 5,382 D
Schambye Hans T. Chief Executive Officer 2026-01-02 Sale −700 $21.38 $14,966 4,682 D
Derivatives
Schambye Hans T. Chief Executive Officer 2026-01-02 Option exercise · Restricted Stock Units −1,360 2,640 D
Open-market sales · 700 sh · avg $21.38 · $14,966
Loading xslF345X05/ownership.xml…